- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Scleroderma, Diffuse
Medical specialists from France tagged as investigators in clinical trials studying Scleroderma, Diffuse
Total 106 results
-
Eric Hachulla, MDSeen in:
- Lille cedex, Department of Internal Medicine Hôpital Claude Huriez
- Lille, CHU Lille
- Lille, Hôpital Claude Huriez
- Nord, Lille, Hôpital Claude Huriez
Trials:- NCT04781543 (Principal Investigator)
- NCT04789850 (Principal Investigator)
- NCT06356740 (Principal Investigator)
- NCT01834157 (Principal Investigator)
-
Estibaliz LAZARO, ProfSeen in:
- Bordeaux, CHU de Bordeaux - Médecine Interne et Immunologie Clinique
- Bordeaux, CHU de Bordeaux - Service d'Immunologie et Immunogénétique
- Bordeaux, CHU de Bordeaux - service de médecine interne
- Bordeaux, CHU de Bordeaux - service de rhumatologie
- Pessac, CHU de Bordeaux - service de médecine interne
Trials:- NCT03698071 (Sub-Investigator)
- NCT05098704 (Sub-Investigator)
- NCT03841318 (Sub-Investigator)
- NCT05698173 (Sub-Investigator)
- NCT04276701 (Sub-Investigator)
- NCT04005638 (Sub-Investigator)
- NCT04265144 (Sub-Investigator)
- NCT05961267 (Sub-Investigator)
Conditions:- ANCA Associated Vasculitis;
- Systemic Sclerosis;
- Scleroderma;
- Sjogren's Syndrome;
- Systemic Lupus Erythematosus;
- Immune Thrombocytopenia;
- Autoimmune Hemolytic Anemia;
- Autoimmune Neutropenia;
- Arthritis, Rheumatoid;
- Lupus Erythematosus, Systemic;
- Scleroderma, Systemic;
- Spondylitis, Ankylosing;
- Mixed Connective Tissue Disease
-
François François, MDSeen in:
- Metz, Hopitaux Prives de Metz
Trials:- NCT02298777 (Principal Investigator)
-
François LIFERMANN, MDSeen in:
- Dax, CH Dax-Côte d'ARgent
- Dax, Centre Hospitalier de Dax
Trials:- NCT05537909 (Principal Investigator)
- NCT04789850 (Principal Investigator)
Conditions: -
Francois PICARD, MDSeen in:
- Bordeaux, CHU de Bordeaux - service de rhumatologie
Trials:- NCT04265144 (Sub-Investigator)
Conditions: -
François-Xavier LAPEBIESeen in:
- Toulouse, Toulouse Hospital
Trials:- NCT04319120 (Principal Investigator)
Conditions: -
Frédérique RETORNAZ, MDSeen in:
- Marseille, Hopital Europeen Marseille
Trials:- NCT04132206 (Sub-Investigator)
Conditions: -
Grégory PugnetSeen in:
- Haute Garonne, Toulouse, GSK Investigational Site
- Haute-Garonne, Toulouse, Hôpital de Rangueil
- Toulouse cedex 9, GSK Investigational Site
- Toulouse, CHU de Toulouse - service de médecine interne
- Toulouse, Rangueil Hospital
Trials:- NCT05878717 (Principal Investigator)
- NCT06411249 (Principal Investigator)
- NCT05098704 (Principal Investigator)
- NCT04781543 (Principal Investigator)
- NCT04789850 (Principal Investigator)
-
Irène LEMELLE, MDSeen in:
- Strasbourg, Service de Pédiatrie 1 - CHU de Strasbourg - France
Trials:- NCT06019234 (Sub-Investigator)
Conditions: -
Jacques MOREL, MD, PhDSeen in:
- Montpellier, CHU Montpellier - rhumatology
- Montpellier, CHU de Montpellier
Trials:- NCT04274374 (Principal Investigator)
- NCT04789850 (Principal Investigator)
Conditions: -
Jean-christophe LEGA, MD, PhDSeen in:
- Lyon, CHU Lyon Sud
Trials:- NCT04789850 (Principal Investigator)
Conditions: -
Jean-Philippe VERNHES, MDSeen in:
- Libourne, CH de Libourne - service de rhumatologie
Trials:- NCT05098704 (Principal Investigator)
Conditions: -
Jérémy KERAEN, MDSeen in:
- Quimper, CH de Cornouaille
Trials:- NCT04789850 (Principal Investigator)
Conditions: -
Joel CONSTANS, MD, PhDSeen in:
- Bordeaux, CHU de Bordeaux - service de rhumatologie
- Bordeaux, Chu Bordeaux
Trials:- NCT04789850 (Principal Investigator)
- NCT05098704 (Sub-Investigator)
- NCT04265144 (Sub-Investigator)
Conditions: -
Jonathan LONDON, MDSeen in:
- Paris, Hospital Croix St Simon
Trials:- NCT04789850 (Principal Investigator)
Conditions: -
Juilien CAMPAGNE, MDSeen in:
- Metz, Robert Schuman Hospital
Trials:- NCT04789850 (Principal Investigator)
Conditions: -
Julien SENESCHAL, ProfSeen in:
- Bordeaux, CHU de Bordeaux - Service d'Immunologie et Immunogénétique
- Bordeaux, CHU de Bordeaux - service de médecine interne
- Bordeaux, CHU de Bordeaux - service de rhumatologie
Trials:- NCT03698071 (Sub-Investigator)
- NCT05098704 (Sub-Investigator)
- NCT04276701 (Sub-Investigator)
- NCT04265144 (Sub-Investigator)
-
Justine BACCHETTA, MDSeen in:
- Bron, Centre de Référence des Maladies Rénales Rares - Hospices Civils de Lyon - Service de Néphrologie et Rhumatologie Pédiatriques - Hôpital Femme Mère Enfant
- Bron, Hospice Civil de Lyon
Trials:- NCT03582800 (Principal Investigator)
- NCT06225882 (Principal Investigator)
-
Korng EA, MDSeen in:
- Paris, APHP - Hôpital Lariboisière
Trials:- NCT03582800 (Principal Investigator)
Conditions: -
Laetitia COUTTE, MDSeen in:
- Boulogne-Billancourt, Ambroise Paré Hospital
Trials:- NCT04789850 (Principal Investigator)
Conditions: -
Laurence BOUILLET, MD, PhDSeen in:
- Grenoble, CHU Grenoble
- Grenoble, CHU Nord de Grenoble - Albert Michallon
Trials:- NCT04789850 (Principal Investigator)
- NCT06356740 (Principal Investigator)
Conditions: -
Laurent CHICHE, MDSeen in:
- Marseille, Hopital Europeen Marseille
Trials:- NCT04132206 (Sub-Investigator)
Conditions: -
Léa JACQUEL, MDSeen in:
- Strasbourg, Laboratoire d'Hématologie - Hôpitaux Universitaires de Strasbourg
- Strasbourg, Service de Pédiatrie 1 - CHU de Strasbourg - France
Trials:- NCT05172778 (Sub-Investigator)
- NCT06019234 (Sub-Investigator)
Conditions: -
Linda ROSSI, MDSeen in:
- Strasbourg, Service de Pédiatrie 1 - CHU de Strasbourg - France
Trials:- NCT06019234 (Sub-Investigator)
Conditions: -
Lucile GRANGE, MDSeen in:
- Saint-Étienne, CHU Saint Etienne
Trials:- NCT04789850 (Principal Investigator)
Conditions: -
Marc ANDRE, MD, PhDSeen in:
- Clermont-Ferrand, CHU Gabriel Montpied
- Clermont-Ferrand, CHU de Clermont-Ferrand - Hopital Gabriel Montpied
Trials:- NCT04789850 (Principal Investigator)
- NCT06356740 (Principal Investigator)
Conditions:
Clinical Trials on Scleroderma, Diffuse
-
Lawson Health Research InstituteNovartis PharmaceuticalsTerminated
-
Gilead SciencesCompletedDiffuse Scleroderma | Limited SclerodermaAustralia
-
Boston UniversityRegeneron PharmaceuticalsCompletedSystemic Sclerosis | Scleroderma | Diffuse Systemic Sclerosis | Diffuse SclerodermaUnited States
-
Michael M. PhamTerminatedSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
Northwestern UniversityCompletedSYSTEMIC SCLERODERMAUnited States
-
BiocadRecruitingSystemic SclerodermaRussian Federation
-
Rennes University HospitalCompleted
-
University of UtahEnrolling by invitationSclerodermaUnited States
-
George Washington UniversityCompleted
-
University of Texas Southwestern Medical CenterCompletedSclerodermaUnited States